
Sign up to save your podcasts
Or
Dr. Bruce Johnson, Chief Clinical Research Officer from the Dana Farber Cancer Institute, joins us to discuss how recent advances in treating rare cancers can help drive the understanding and expansion of precision medicine.
4.8
3131 ratings
Dr. Bruce Johnson, Chief Clinical Research Officer from the Dana Farber Cancer Institute, joins us to discuss how recent advances in treating rare cancers can help drive the understanding and expansion of precision medicine.
38,598 Listeners
43,979 Listeners
8,667 Listeners
32,094 Listeners
43,712 Listeners
1,448 Listeners
9,516 Listeners
9,176 Listeners
317 Listeners
8,023 Listeners
14,345 Listeners
5,399 Listeners
2,121 Listeners
48 Listeners
5 Listeners